Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging (NCT07431203) | Clinical Trial Compass
CompletedNot Applicable
Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging
France100 participantsStarted 2025-10-13
Plain-language summary
The goal of this observational study is to evaluate the effect of age on skin microbiome.
Who can participate
Age range
25 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Healthy subject;
. Sex: female
. Age: 50% having between 25 to 35 years old or 50% between 55 to 65 years old
. Type: Caucasian
. Phototype: I to III on the Fitzpatrick scale
. Subject, having given freely and expressly her informed consent.
. Subject, psychologically able to understand the study related information and to give a written informed consent;
. Subject able to comply with protocol requirements;
Exclusion criteria
. Pregnant or nursing woman or planning a pregnancy during the study;
. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
. Subject who is under guardianship or who is not able to express her consent;
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
. Subject suspected to be non-compliant according to the investigator's judgment;
. Subject having received 6000 euros indemnities for participation in a clinical research in the 12 previous months, including participation in the present study;
. Subject enrolled in another clinical trial or which exclusion period is not over.
. Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk or which may interfere with the evaluation;